Insiders · Profile

Friberg Gregory R

EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL. Filing since 26 Feb 2026. CIK 0002038768

Company

Date

Role

Action

Amount

Of holding

7 May 2026

EVP, Chief R&D Officer

Sold at will

3,281

$176.68K

6.0%

26 Feb 2026

EVP, Chief R&D Officer

Sold at will

6,326

$381.94K

14.4%

2 decisions on file.